Electromed Total Operating Expenses vs Cost Of Revenue Analysis

ELMD Stock

USD 30.78 0.28 0.90%

Electromed financial indicator trend analysis is much more than just examining Electromed latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Electromed is a good investment. Please check the relationship between Electromed Total Operating Expenses and its Cost Of Revenue accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.

Total Operating Expenses vs Cost Of Revenue

Total Operating Expenses vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Electromed Total Operating Expenses account and Cost Of Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Electromed's Total Operating Expenses and Cost Of Revenue is 0.98. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Electromed, assuming nothing else is changed. The correlation between historical values of Electromed's Total Operating Expenses and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of Electromed are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Total Operating Expenses i.e., Electromed's Total Operating Expenses and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.98

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Cost Of Revenue

Cost of Revenue is found on Electromed income statement and represents the costs associated with goods and services Electromed provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Electromed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Electromed current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.At present, Electromed's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 14.88, whereas Selling General Administrative is forecasted to decline to about 18.5 M.

	2021	2022	2023	2024 (projected)
Interest Expense	25K	78K	89.7K	85.2K
Depreciation And Amortization	628K	613K	841K	684.7K

Interest Expense Depreciation And Amortization

Electromed fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		-0.73	0.81	0.89	0.99	0.83	-0.79	0.87	0.8	0.74	0.88	0.31	0.47	0.74	0.98	0.77	0.74	-0.8	0.85	0.4	0.74	0.67	0.57	1.0	-0.21	-0.25
Short Long Term Debt Total	-0.73		-0.64	-0.46	-0.78	-0.67	0.82	-0.75	-0.46	-0.74	-0.65	-0.23	-0.38	-0.74	-0.66	-0.7	-0.81	0.89	-0.63	-0.07	-0.72	-0.13	-0.49	-0.73	0.66	0.25
Other Current Liab	0.81	-0.64		0.85	0.78	0.71	-0.79	0.93	0.75	0.79	0.74	0.35	0.35	0.79	0.83	0.49	0.5	-0.67	0.64	0.39	0.43	0.76	0.76	0.81	-0.25	-0.49
Total Current Liabilities	0.89	-0.46	0.85		0.84	0.76	-0.59	0.77	0.93	0.57	0.82	0.41	0.49	0.57	0.93	0.54	0.49	-0.6	0.77	0.65	0.57	0.91	0.53	0.88	0.03	-0.29
Total Stockholder Equity	0.99	-0.78	0.78	0.84		0.82	-0.81	0.86	0.75	0.75	0.86	0.28	0.47	0.75	0.96	0.8	0.78	-0.84	0.85	0.35	0.77	0.58	0.54	0.99	-0.25	-0.23
Property Plant And Equipment Net	0.83	-0.67	0.71	0.76	0.82		-0.55	0.71	0.78	0.48	0.98	0.28	0.42	0.48	0.85	0.74	0.63	-0.63	0.85	0.47	0.71	0.61	0.61	0.8	-0.36	0.02
Net Debt	-0.79	0.82	-0.79	-0.59	-0.81	-0.55		-0.93	-0.46	-0.99	-0.6	-0.1	-0.12	-0.99	-0.7	-0.71	-0.75	0.85	-0.61	0.05	-0.63	-0.36	-0.74	-0.8	0.37	0.38
Retained Earnings	0.87	-0.75	0.93	0.77	0.86	0.71	-0.93		0.68	0.93	0.75	0.2	0.26	0.93	0.84	0.68	0.71	-0.8	0.72	0.21	0.6	0.61	0.8	0.87	-0.27	-0.37
Accounts Payable	0.8	-0.46	0.75	0.93	0.75	0.78	-0.46	0.68		0.43	0.83	0.5	0.57	0.43	0.87	0.55	0.55	-0.58	0.77	0.79	0.63	0.84	0.45	0.79	0.01	-0.09
Cash	0.74	-0.74	0.79	0.57	0.75	0.48	-0.99	0.93	0.43		0.54	0.06	0.04	1.0	0.65	0.66	0.69	-0.78	0.56	-0.09	0.56	0.38	0.78	0.75	-0.29	-0.38
Non Current Assets Total	0.88	-0.65	0.74	0.82	0.86	0.98	-0.6	0.75	0.83	0.54		0.3	0.39	0.54	0.9	0.78	0.66	-0.65	0.86	0.47	0.75	0.68	0.65	0.85	-0.29	0.02
Non Currrent Assets Other	0.31	-0.23	0.35	0.41	0.28	0.28	-0.1	0.2	0.5	0.06	0.3		0.54	0.06	0.36	0.08	0.17	-0.22	0.22	0.7	0.17	0.37	0.01	0.3	-0.1	-0.15
Other Assets	0.47	-0.38	0.35	0.49	0.47	0.42	-0.12	0.26	0.57	0.04	0.39	0.54		0.04	0.55	0.04	0.27	-0.36	0.43	0.69	0.22	0.35	-0.25	0.48	-0.21	-0.29
Cash And Short Term Investments	0.74	-0.74	0.79	0.57	0.75	0.48	-0.99	0.93	0.43	1.0	0.54	0.06	0.04		0.65	0.66	0.69	-0.78	0.56	-0.09	0.56	0.38	0.78	0.75	-0.29	-0.38
Net Receivables	0.98	-0.66	0.83	0.93	0.96	0.85	-0.7	0.84	0.87	0.65	0.9	0.36	0.55	0.65		0.7	0.68	-0.75	0.83	0.53	0.69	0.74	0.53	0.97	-0.15	-0.22
Common Stock Total Equity	0.77	-0.7	0.49	0.54	0.8	0.74	-0.71	0.68	0.55	0.66	0.78	0.08	0.04	0.66	0.7		0.9	-0.79	0.76	0.11	0.93	0.28	0.62	0.75	-0.17	0.29
Common Stock Shares Outstanding	0.74	-0.81	0.5	0.49	0.78	0.63	-0.75	0.71	0.55	0.69	0.66	0.17	0.27	0.69	0.68	0.9		-0.92	0.72	0.19	0.92	0.16	0.46	0.73	-0.19	0.17
Non Current Liabilities Total	-0.8	0.89	-0.67	-0.6	-0.84	-0.63	0.85	-0.8	-0.58	-0.78	-0.65	-0.22	-0.36	-0.78	-0.75	-0.79	-0.92		-0.72	-0.23	-0.82	-0.25	-0.48	-0.81	0.26	0.16
Inventory	0.85	-0.63	0.64	0.77	0.85	0.85	-0.61	0.72	0.77	0.56	0.86	0.22	0.43	0.56	0.83	0.76	0.72	-0.72		0.49	0.77	0.57	0.5	0.84	-0.13	-0.06
Other Current Assets	0.4	-0.07	0.39	0.65	0.35	0.47	0.05	0.21	0.79	-0.09	0.47	0.7	0.69	-0.09	0.53	0.11	0.19	-0.23	0.49		0.27	0.64	-0.05	0.39	0.25	-0.01
Other Stockholder Equity	0.74	-0.72	0.43	0.57	0.77	0.71	-0.63	0.6	0.63	0.56	0.75	0.17	0.22	0.56	0.69	0.93	0.92	-0.82	0.77	0.27		0.28	0.45	0.73	-0.16	0.26
Total Liab	0.67	-0.13	0.76	0.91	0.58	0.61	-0.36	0.61	0.84	0.38	0.68	0.37	0.35	0.38	0.74	0.28	0.16	-0.25	0.57	0.64	0.28		0.52	0.66	0.15	-0.29
Property Plant And Equipment Gross	0.57	-0.49	0.76	0.53	0.54	0.61	-0.74	0.8	0.45	0.78	0.65	0.01	-0.25	0.78	0.53	0.62	0.46	-0.48	0.5	-0.05	0.45	0.52		0.55	-0.25	-0.12
Total Current Assets	1.0	-0.73	0.81	0.88	0.99	0.8	-0.8	0.87	0.79	0.75	0.85	0.3	0.48	0.75	0.97	0.75	0.73	-0.81	0.84	0.39	0.73	0.66	0.55		-0.2	-0.28
Short Term Debt	-0.21	0.66	-0.25	0.03	-0.25	-0.36	0.37	-0.27	0.01	-0.29	-0.29	-0.1	-0.21	-0.29	-0.15	-0.17	-0.19	0.26	-0.13	0.25	-0.16	0.15	-0.25	-0.2		0.31
Intangible Assets	-0.25	0.25	-0.49	-0.29	-0.23	0.02	0.38	-0.37	-0.09	-0.38	0.02	-0.15	-0.29	-0.38	-0.22	0.29	0.17	0.16	-0.06	-0.01	0.26	-0.29	-0.12	-0.28	0.31

Click cells to compare fundamentals

Electromed Account Relationship Matchups

Electromed fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.2M	37.1M	41.4M	45.8M	52.2M	28.3M
Short Long Term Debt Total	45.1K	81.2K	87K	41K	161K	82.7K
Other Current Liab	2.4M	3.7M	5.8M	6.3M	6.4M	6.7M
Total Current Liabilities	3.0M	4.6M	7.2M	8.1M	7.7M	4.5M
Total Stockholder Equity	30.2M	32.4M	34.2M	37.7M	44.5M	22.6M
Property Plant And Equipment Net	3.9M	3.7M	4.7M	5.7M	5.3M	4.0M
Net Debt	(10.4M)	(11.8M)	(8.1M)	(7.2M)	(16.1M)	(15.3M)
Retained Earnings	13.7M	14.9M	15.8M	18.8M	23.7M	24.9M
Accounts Payable	555.5K	685K	1.3M	1.4M	1.0M	814.3K
Cash	10.5M	11.9M	8.2M	7.4M	16.1M	16.9M
Non Current Assets Total	5.2M	5.4M	6.8M	8.0M	8.1M	5.6M
Non Currrent Assets Other	80.2K	88K	120M	161K	87K	82.7K
Other Assets	755K	1.1M	1.5M	1.6M	1.0	0.95
Cash And Short Term Investments	10.5M	11.9M	8.2M	7.4M	16.1M	16.9M
Net Receivables	14.1M	17.4M	21.3M	24.6M	24.1M	13.3M
Common Stock Total Equity	84.1K	85.7K	85K	86K	98.9K	86.6K
Common Stock Shares Outstanding	8.8M	8.9M	8.8M	8.7M	8.9M	8.9M
Liabilities And Stockholders Equity	33.2M	37.1M	41.4M	45.8M	52.2M	28.3M
Non Current Liabilities Total	8.9K	54K	41K	86K	12K	11.4K
Inventory	3.1M	2.1M	3.2M	4.2M	3.7M	2.6M
Other Current Assets	353.3K	276K	1.9M	1.6M	329.0K	312.6K
Other Stockholder Equity	16.5M	17.4M	18.3M	18.8M	20.8M	16.5M
Total Liab	3.0M	4.7M	7.2M	8.1M	7.7M	5.6M
Property Plant And Equipment Gross	3.8M	3.6M	4.7M	5.7M	10.4M	10.9M
Total Current Assets	28.0M	31.7M	34.5M	37.8M	44.2M	22.7M
Short Term Debt	30.3K	72.3K	33K	80K	72K	68.4K
Intangible Assets	598.4K	663K	599K	605K	657K	624.2K
Common Stock	84.1K	85.7K	85K	86K	87K	87.1K
Property Plant Equipment	3.9M	3.6M	4.6M	5.7M	6.5M	3.9M
Current Deferred Revenue	(72.3K)	(33K)	1.5B	(80K)	277K	263.2K
Net Tangible Assets	29.7M	31.8M	33.6M	37.1M	42.6M	24.2M
Retained Earnings Total Equity	13.7M	14.9M	15.8M	18.8M	21.6M	22.7M
Capital Surpluse	16.5M	17.4M	18.3M	18.8M	21.6M	16.7M
Net Invested Capital	30.2M	32.4M	34.2M	37.7M	44.5M	34.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports:

How To Invest In Electromed

Details

Is Electromed Stock a good investment?

Details

What is Electromed's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.

You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.809

Earnings Share

0.72

Revenue Per Share

6.39

Quarterly Revenue Growth

0.09

Return On Assets

0.0839

The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Electromed Total Operating Expenses vs Cost Of Revenue Analysis

Total Operating Expenses vs Cost Of Revenue

Total Operating Expenses vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Total Operating Expenses

Cost Of Revenue

Electromed fundamental ratios Correlations

Electromed Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Electromed fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity
Net Receivables	+ 0.98	Total Assets
Non Current Assets Total	+ 0.98	Property Plant And Equipment Net

Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Retained Earnings	- 0.93	Net Debt
Non Current Liabilities Total	- 0.92	Common Stock Shares Outstanding
Non Current Liabilities Total	- 0.84	Total Stockholder Equity
Other Stockholder Equity	- 0.82	Non Current Liabilities Total